153 related articles for article (PubMed ID: 23683596)
1. Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication.
Chen G; Ren H; Turpoff A; Arefolov A; Wilde R; Takasugi J; Khan A; Almstead N; Gu Z; Komatsu T; Freund C; Breslin J; Colacino J; Hedrick J; Weetall M; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3942-6. PubMed ID: 23683596
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B.
Zhang N; Zhang X; Zhu J; Turpoff A; Chen G; Morrill C; Huang S; Lennox W; Kakarla R; Liu R; Li C; Ren H; Almstead N; Venkatraman S; Njoroge FG; Gu Z; Clausen V; Graci J; Jung SP; Zheng Y; Colacino JM; Lahser F; Sheedy J; Mollin A; Weetall M; Nomeir A; Karp GM
J Med Chem; 2014 Mar; 57(5):2121-35. PubMed ID: 24266880
[TBL] [Abstract][Full Text] [Related]
4. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.
Andreev IA; Manvar D; Barreca ML; Belov DS; Basu A; Sweeney NL; Ratmanova NK; Lukyanenko ER; Manfroni G; Cecchetti V; Frick DN; Altieri A; Kaushik-Basu N; Kurkin AV
Eur J Med Chem; 2015; 96():250-8. PubMed ID: 25890075
[TBL] [Abstract][Full Text] [Related]
6. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
[TBL] [Abstract][Full Text] [Related]
9. 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B.
Chen G; Ren H; Zhang N; Lennox W; Turpoff A; Paget S; Li C; Almstead N; Njoroge FG; Gu Z; Graci J; Jung SP; Colacino J; Lahser F; Zhao X; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2015 Feb; 25(4):781-6. PubMed ID: 25613678
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
[TBL] [Abstract][Full Text] [Related]
11. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B.
Zhang N; Turpoff A; Zhang X; Huang S; Liu Y; Almstead N; Njoroge FG; Gu Z; Graci J; Jung SP; Pichardo J; Colacino J; Lahser F; Ingravallo P; Weetall M; Nomeir A; Karp GM
Bioorg Med Chem Lett; 2016 Jan; 26(2):594-601. PubMed ID: 26652483
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.
Kang IJ; Wang LW; Yeh TK; Lee CC; Lee YC; Hsu SJ; Wu YS; Wang JC; Chao YS; Yueh A; Chern JH
Bioorg Med Chem; 2010 Sep; 18(17):6414-21. PubMed ID: 20675142
[TBL] [Abstract][Full Text] [Related]
14. Novel substituted pyrimidines as HCV replication (replicase) inhibitors.
Kwong CD; Clark JL; Fowler AT; Geng F; Kezar HS; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Shih NY; Piwinski JJ; Li C; Feld B; Huang HC; Tong X; George Njoroge F; Arasappan A
Bioorg Med Chem Lett; 2012 Jan; 22(2):1160-4. PubMed ID: 22178556
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
[TBL] [Abstract][Full Text] [Related]
16. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
Selvam P; Murugesh N; Chandramohan M; Sidwell RW; Wandersee MK; Smee DF
Antivir Chem Chemother; 2006; 17(5):269-74. PubMed ID: 17176631
[TBL] [Abstract][Full Text] [Related]
17. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
Venkatraman S; Blackman M; Wu W; Nair L; Arasappan A; Padilla A; Bogen S; Bennett F; Chen K; Pichardo J; Tong X; Prongay A; Cheng KC; Girijavallabhan V; George Njoroge F
Bioorg Med Chem; 2009 Jul; 17(13):4486-95. PubMed ID: 19481946
[TBL] [Abstract][Full Text] [Related]
19. Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development.
Nair AG; Zeng Q; Selyutin O; Rosenblum SB; Jiang Y; Yang DY; Keertikar K; Zhou G; Dwyer MP; Kim SH; Shankar B; Yu W; Tong L; Chen L; Mazzola R; Caldwell J; Tang H; Allard ML; Buckle RN; Gauuan PJ; Holst CL; Martin GS; Naicker KP; Vellekoop S; Agrawal S; Liu R; Kong R; Ingravallo P; Xia E; Zhai Y; Nomeir A; Kozlowski JA
Bioorg Med Chem Lett; 2016 Mar; 26(5):1475-9. PubMed ID: 26850003
[TBL] [Abstract][Full Text] [Related]
20. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
